Skip to content
Institutional Investor later-stage private (late clinical Phase II/III profitable/cash flow-neutral) growth follow-on post-IPO public buyout Est. 2001

HBM Healthcare Investments

Life sciences focused VC firm funding companies in the US and Europe

📍 Zug, Switzerland
Website ↗ LinkedIn ↗ Twitter ↗

About This Fund

HBM Healthcare Investments is a venture capital firm. Geographies of interest include the US and Europe. Invests in life sciences companies specializing in areas such as Diagnostics, BioTech, Biopharma and Medical Devices. Notable investments include PTC Therapeutics, Nabriva Therapeutics, Paratek Pharmaceuticals, Armo BioSciences.

Investment Focus

Sectors
biotechnology medical technology diagnostics human medicine biopharma digital health
Stages
later-stage private (late clinical Phase II/III profitable/cash flow-neutral) growth follow-on post-IPO public buyout
Check Size $5M-$50M
Geography
Global USA Europe Asia

What They Look For

later-stage companies with proof-of-concept or advanced products (Phase II+, market-ready); revenue-generating or cash flow-neutral preferred; strong business model, pipeline, technology, management; attractive valuation/risk-reward; global (primarily Europe, North America, Asia); HBM influence possible (board/majority stake)

Related Funds

Browse all funds →

Preparing to pitch HBM Healthcare Investments?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →